|
Dr. Renato Dellamano President |
Dr. Dellamano, President and founder of ValueVector, is the former Head of Strategic Pricing at the global Headquarters of the Swiss pharmaceutical giant Hoffmann-La Roche.
In the seven years (from 1996 to 2003) he held this position, Dr. Dellamano was instrumental in analyzing and developing global pricing and reimbursement strategies for products in many different therapeutic areas, including: |
Cardiovascular Diseases
Central Nervous System
Dermatology
Infectious Diseases
Inflammatory and Autoimmune diseases
Metabolic Disorders
Oncology
Rare diseases and Orphan therapies
Transplantations
Vaccines
Virology
|
 |
Before heading the Strategic Pricing function, Dr. Dellamano spent almost two years in Basel as Global Controller of the Pharma Division of Hoffmann-La Roche. Previously, he held senior managerial positions at the Italian Affiliate of Hoffmann-La Roche, where – between 1989 and 1994 – he headed the Business Development and the Strategic Planning functions.
A Health Economist and a former professor of Hospital Management, Dr. Dellamano combines a solid methodological background with global and local extensive business experience in the areas of strategic planning, business development, pharmaceutical pricing, reimbursement and health economics. |
|